Please login to the form below

Not currently logged in
Email:
Password:

New executive at PhRMA

Pharmaceutical Research and Manufacturers of America, the industry's main US trade group, has confirmed former IBM executive Rod Hunter as the organisation's new senior vice president of international advocacy

Pharmaceutical Research and Manufacturers of America (PhRMA), the industry's main US trade group, has confirmed former IBM executive Rod Hunter as the organisation's new senior vice president of international advocacy, effective June 10.

Hunter will be responsible for leading and overseeing PhRMA's international advocacy functions, reporting to executive vice president of advocacy Chip Davis.

At IBM, Hunter served as vice president, governmental programmes, Europe. Earlier in his career, he served as special assistant to the president and senior director of the White House's National Security Council under President George W Bush, coordinating the administration's international economic agenda, including trade, intellectual property, investment, energy and environmental policies.

"With his broad international trade experience in both the private and public sectors, Rod brings to bear a keen understanding of the complex policies and market dynamics inherent to an increasingly global economy," Davis said in a statement.

13th May 2011

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
M3 (EU)

M3 is the world’s largest network of verified doctors with over 6 million members across key markets; our closed and...

Latest intelligence

Webinar:
Securing a future for telehealth with immersive market research insights...
Accelerating patient recruitment in clinical trials with the Clinical Enrolment Managers (CEMs)
How Innovative Trials' global Clinical Enrolment Managers (CEMs) give clinical trial sites the local touch...
Six ways to improve diversity in clinical trials
Diversity is becoming increasingly important as a focus of clinical trials. This whitepaper gives six approaches that could be implemented to help make diversity a bigger focus on your clinical...